Analyzing the Factors Influencing Mortality in Saudi Arabia
Main Article Content
Abstract
Background: Non-communicable diseases (NCDs) are a leading cause of death worldwide, and their prevalence is increasing in Saudi Arabia due to unhealthy lifestyles and longer life expectancy. This research aims to investigate the primary causes of mortality in Saudi Arabia and develop healthcare management strategies to improve mortality outcomes, reduce preventable deaths, and enhance the delivery of healthcare services.
Method: The analysis of death rates and non-communicable diseases in Saudi Arabia from 2017 to 2021 relies on secondary quantitative data obtained from local statistics provided by GASTAT and WHO. The study encompasses the complete population of Saudi Arabia, and statistical analysis is conducted using IBM SPSS Statistics version 27 and Microsoft Excel.
Results: Upon analyzing death rates in Saudi Arabia over a span of five years, it becomes evident that non-communicable diseases are the main factors responsible for the rise in mortality. Differences in death rates are noted between adult females and men, with standard deviations (SD) of 3.69 for females and 3.53 for males. Ischemic Heart Disease exhibits a greater average death rate in males (133.25) than in females (87.84), followed by Stroke, Neoplasms, Kidney disorders, and Diabetes Mellitus. The regression model demonstrates the substantial influence of various causes of death on mortality rates, providing a reliable structure for forecasting these rates (p < 0.001).
Conclusion: In order to successfully tackle the main causes of death, Saudi Arabia needs to implement comprehensive policy measures to oversee healthcare. The measures encompass public health campaigns, wellness programs, early detection initiatives, government funding for medical research, regulatory actions, and laws that encourage healthy lives.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
World Health Organization. Noncommunicable diseases: Key facts. World Health Organization. ; 2018. Available from: https:/ www.who.int/news-room/fact-sheets/detail/noncommunicable- diseases. (Accessed 28 Sep 2023).
World Health Organization. Noncommunicable diseases country profiles 2018. World Health Organization. ; 2018. Available from: https:/ iris.who.int/handle/10665/274512. License: CC BY-NC- SA 3.0 IGO.
Al-Hanawi MK. Socioeconomic determinants and inequalities in the prevalence of non- communicable diseases in Saudi Arabia. Int J Equity Health. 2021;20(1):174.
https:/ doi.org/10.1186/s12939-021-01510-6.
Rakic S, Albalawi S, Alsukait R, Alqunaibet A. Prevalence and Risk Factors of NCDs in Saudi Arabia. 2021. 10.1596/978-1-4648-1717-5_ch2.
Hazazi A, Wilson A. Noncommunicable diseases and health system responses in Saudi Arabia: focus on policies and strategies. Health Res Policy Syst. 2022;20(1):63. https:/ doi.org/10.1186/s12961- 022-00872-9.
Bruckner T, Lee E, Alqunaibet A, Finkelstein E, Herbst C, Almudarra S. Forecasting the Health Burden of NCDs in Saudi Arabia. 2021. 10.1596/978-1-4648-1717-5_ch3.
Grafton D, Elmusharaf K, Jung J, Adam I, Alomary SA, Humieda A, Elimam M. THE CASE FOR INVESTMENT IN THE PREVENTION AND CONTROL OF NON-COMMUNICABLE DISEASES IN THE KINGDOM OF SAUDI ARABIA. 2021.
Ministry of Health Kingdom of Saudi Arabia. World Health Survey Saudi Arabia. 2019. 2019. Available at https:/ www.moh.gov.sa/en/Ministry/Statistics/Population- HealthIndicators/Documents/World-Health-Survey-Saudi-Arabia.pdf.
Al Jawaldeh A, Rafii B, Nasreddine L. Salt intake reduction strategies in the Eastern Mediterranean Region. East Mediterr Health J. 2019;24(12):1172–80. https:/ doi.org/10.26719/emhj.18.006.
World Health Organization. WHO announces certification programme for trans-fat elimination. 2020. Available at https:/ www.who.int/news/item/17-11-2020-whoannounces-certification-programme- for-trans-fat-elimination (Accessed SEP. 29, 2023).
Kingdom of Saudi Arabia. Inclusion of sugar sweetened beverages and other tobacco products in the Excise Tax System. PWC. 2019. Available at KSA: Inclusion of sugar sweetened beverages and other tobacco products in the Excise Tax System (pwc.com).
Al-zalabani A, Al-Hamdan N, Saeed A. The prevalence of physical activity and its socioeconomic correlates in Kingdom of Saudi Arabia: A cross-sectional population-based national survey. J Taibah Univ Med Sci. 2015. 10.1016/j.jtumed.2014.11.001.
United Nations Saudi Arabia, U. N. Toward’s Saudi Arabia’s Sustainable Tomorrow in Saudi Arabia. 2018. Available at https:/ saudiarabia.un.org/en/35915-towards-saudi-arabias-sustainable- tomorrow.
Ministry of Health Saudi Arabia. Anti-smoking law - MOH. 2019. Available at https:/ www.moh.gov.sa/en/Ministry/Rules/Documents/Anti-Tobacco-Executive-Regulations.pdf.
Alghamdi A, Fallatah A, Okal F, Felemban T, Eldigire M, Almodaimegh H. Smoking behaviour after enforcement of a 100% tax on tobacco products in Saudi Arabia: a cross-sectional study. East Mediterr Health J. 2020;26(1):39–46. https:/ doi.org/10.26719/2020.26.1.39.
Hazazi A, Wilson A. Improving Management of Non-communicable Chronic Diseases in Primary Healthcare Centres in The Saudi Health Care System. Health Serv Insights. 2022;15:11786329221088694. https:/ doi.org/10.1177/1178632922108869.
IHME. Saudi Health Interview Results. 2014. Retrieved from https:/ www.healthdata.org/sites/default/files/files/Projects/KSA/Saudi-Health-Interview-Survey- Results.pdf.
Mays GP, Smith SA. Evidence links increases in public health spending to declines in preventable deaths. Health Aff (Millwood). 2011;30:1585–1593. https:/ doi.org/[DOI].
Cutler DM. Are we finally winning the war on cancer? J Econ Perspect. 2008;22:3–26. https:/ doi.org/[DOI].
Whear R, Thompson-Coon J, Rogers M, Abbott RA, Anderson L, Ukoumunne O, Matthews J, Goodwin VA, Briscoe S, Perry M et al. Patient-initiated appointment systems for adults with chronic conditions in secondary care. Cochrane Database Syst Rev. 2020;4:CD010763. https:/ doi.org/[DOI].
Alhabib KF, Batais MA, Almigbal TH, et al. Demographic, behavioral, and cardiovascular disease risk factors in the Saudi population: Results from the Prospective Urban Rural Epidemiology study (PURE- Saudi). BMC Public Health. 2020;20:1213. https:/ doi.org/10.1186/s12889-020-09298-w.
Al-Hamdan N, Kutbi A, Choudhry A, Nooh R, Shoukri M, Mujib S. WHO stepwise approach to NCD surveillance country-specific standard report Saudi Arabia. 2005. Ministry of Health, Kingdom of Saudi Arabia, in collaboration with World Health Organization, EMRO.
AlHabib KF, Elasfar AA, Alfaleh H, Kashour T, Hersi A, AlBackr H, et al. Clinical features, management, and short- and long-term outcomes of patients with acute decompensated heart failure: Phase I results of the HEARTS database. Eur J Heart Fail. 2014;16(4):461–9.
AlHabib KF, Hersi A, AlFaleh H, AlNemer K, AlSaif S, Taraben A, et al. Baseline characteristics, management practices, and in-hospital outcomes of patients with acute coronary syndromes: Results of the Saudi project for assessment of coronary events (SPACE) registry. J Saudi Heart Assoc. 2011;23(4):233–9.
Alhabib KF, Kinsara AJ, Alghamdi S, Al-Murayeh M, Hussein GA, AlSaif S, et al. The first survey of the Saudi acute myocardial infarction registry program: Main results and long-term outcomes (STARS-1 program). PLoS ONE. 2019;14(5):e0216551.
Roper NA, Bilous RW, Kelly WF, Unwin NC, Connolly VM. Cause-specific mortality in a population with diabetes: South Tees diabetes mortality study. Diabetes Care. 2002;25(1):43–8.
Cho N, Kirigia J, Mbanya J, Ogurstova K, Guariguata L, Rathmann W. IDF diabetes atlas-eighth. Int Diabetes Federation. 2017. http:/ fmdiabetes.org/wp-content/uploads/2018/03/IDF-2017.pdf.
Memish ZA, El Bcheraoui C, Tuffaha M, Robinson M, Daoud F, Jaber S et al. Obesity and associated factors—Kingdom of Saudi Arabia, 2013. Prev Chronic Dis. 2014;11:140236. https:/ doi.org/10.5888/pcd11.140236 PMID: 25299980.
National Committee on Tobacco Control. Saudi guideline for tobacco. 2019. Retrieved from http:/ nctc.gov.sa/Content/Upload/PDF/pdfFile2019_7_25501909123948.PDF.
Saudi Centre for Disease Prevention and Control. Obesity control & prevention strategy 2030. 2019. Retrieved from https:/ www.ianphi.org/_includes/documents/sections/tools-resources/annual- meetings/2019annualmeeting/obesity-prevention-control-strategy.pdf.
Al Eid AJ, Alahmed ZA, Al-Omary SA, Alharbi SM. RASHAKA Program: A collaborative initiative between Ministry of Health and Ministry of Education to control childhood obesity in Saudi Arabia. Saudi J Obes. 2017;5(1):22–7. https:/ doi.org/10.4103/sjo.sjo_5_17.
Saudi Commission for Health Specialties. Saudi hypertension guidelines. Riyadh. Saudi Arabia: King Fahd National Library Cataloguing-in-Publication Data; 2018.
Government of Saudi Arabia. KSA national strategy for diet and physical activity for the years 2014– 2025. Saudi Arabia; 2014.
Katar I. Promoting pedestrian ecomobility in Riyadh City for sustainable urban development. Sci Rep. 2022;12(1):14808. https:/ doi.org/10.1038/s41598-022-18183-y.
World Heart Federation. CVD Roadmaps. 2014. Retrieved from https:/ world-heart- federation.org/cvd roadmaps/.
Herzallah HK, Antonisamy BR, Shafee MH, Al-Otaibi ST. Temporal trends in the incidence and demographics of cancers, communicable diseases, and non-communicable diseases in Saudi Arabia over the last decade. Saudi Med J. 2019;40(3):277–86. https:/ doi.org/10.15537/smj.2019.3.23585.
Elmusharaf K, Grafton D, Jung JS, et al. The case for investing in the prevention and control of non- communicable diseases in the six countries of the Gulf Cooperation Council: an economic evaluation. BMJ Global Health. 2022;7:e008670. 10.1136/bmjgh-2022-008670.
Al Saffer Z, Mogheer M, Al Yami M, Al Yamani A, Almarhabi A, Al Turki Y, et al. Factors associated with medication adherence in patients attending primary health care in Saudi Arabia: a cross- sectional study. BMC Health Serv Res. 2021;21(365). https:/ doi.org/10.1186/s12913-021-06355-x.
Hazazi AM, Wilson K. Factors influencing adherence to lifestyle recommendations in Saudi Arabian primary health care: A cross-sectional study. BMC Fam Pract. 2021;22(106). https:/ doi.org/10.1186/s12875-021-01456-2.
Larkin J, Foley L, Smith SM, Harrington P, Clyne B. The experience of financial burden for people with multimorbidity: A systematic review of qualitative research. Health Expect. 2021;24:282–95.
Sum G, Hone T, Atun R, Millett C, Suhrcke M, Mahal A, Koh GC, Lee JT. Multimorbidity and out-of- pocket expenditure on medicines: A systematic review. BMJ Global Health. 2018;3:e000505.
Schoen C, Osborn R, How SK, Doty MM, Peugh J. chronic condition: Experiences of patients with complex health care needs, in eight countries, 2008. Health Aff (Millwood). 2009;28:w1–16.
Winter SJ, King AC, Stafford RS, Winkleby MA, Haskell WL, Farquhar JW. Promoting culturally targeted chronic disease prevention research through an adapted participatory research approach: The Qassim-Stanford Universities project. Transl Behav Med. 2011;1:289–98.